MicroMatrix® MM0100Recalls & reported problems
Acell, Inc. · MicroMatrix® UBM Standard Particulate, 100mg · Class U
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00386190001158), received between Jan 6, 2020 and Jan 6, 2020 — classified as 2 injuries.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method2
- Off-Label Use2
- Use of Device Problem2
Patient problems
- Unspecified Infection2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJan 6, 2020Off-Label Use; Use of Device Problem; Improper or Incorrect Procedure or Method; Off-Label Use; Use of Device Problem; Improper or Incorrect Procedure or Method
ON 12/9/2019 ACELL RECEIVED NOTIFICATION FROM A PHYSICIAN THAT A PATIENT DEVELOPED AN INFECTION AFTER A HAIR RESTORATION PROCEDURE WHICH INVOLVED SCALP INJECTIONS WITH MICROMATRIX RECONSTITUTED WITH PLATELET RICH PLASMA (PRP). THE PROCEDURE WAS CONDUCTED ON (B)(6) 2019, PATIENT REPORTED SYMPTOMS THREE (3) DAYS POST PROCEDURE. THE PHYSICIAN PRESCRIBED THE ANTIBIOTICS CIPRO.
Patient problems: Unspecified Infection
MAUDE report 9555731 ↗InjuryJan 6, 2020Off-Label Use; Use of Device Problem; Improper or Incorrect Procedure or Method; Off-Label Use; Use of Device Problem; Improper or Incorrect Procedure or Method
ON 12/9/2019 ACELL RECEIVED NOTIFICATION FROM A PHYSICIAN THAT A PATIENT DEVELOPED AN INFECTION AFTER A HAIR RESTORATION PROCEDURE WHICH INVOLVED SCALP INJECTIONS WITH MICROMATRIX RECONSTITUTED WITH PLATELET RICH PLASMA (PRP). THE PROCEDURE WAS CONDUCTED ON (B)(6) 2019, PATIENT REPORTED SYMPTOMS TWO (2) TO THREE (3) DAYS POST PROCEDURE. THE PHYSICIAN PRESCRIBED THE ANTIBIOTICS CIPRO.
Patient problems: Unspecified Infection
MAUDE report 9555698 ↗
Other DRESSING, WOUND, COLLAGEN devices
- Cytal® WSM0505Acell, Inc. · DRESSING, WOUND, COLLAGEN1 recall0 reports
- Cytal® BMM0710Acell, Inc. · DRESSING, WOUND, COLLAGEN1 recall0 reports
- Cytal® WSM0710Acell, Inc. · DRESSING, WOUND, COLLAGEN1 recall0 reports
- PriMatrix® 607-001-125Tei Biosciences Inc. · DRESSING, WOUND, COLLAGEN1 recall0 reports
- DermaCol 100 00300ESion Brands LLC · Dressing, Wound, Collagen1 recall0 reports
- DermaCol 100 00300ESion Brands LLC · Dressing, Wound, Collagen1 recall0 reports
- PriMatrix® 607-004-880Tei Biosciences Inc. · DRESSING, WOUND, COLLAGEN1 recall0 reports
- GIBSON HEALTHCARE 5251-194Benco Dental Supply CO. · Dressing, Wound, Collagen1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page